Top 10 Medical Device Angel Investors in Oceania (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Allan Moss
Angel
|
2 | Australia, United States, The Netherlands | Venture - Series Unknown, Series A, Seed | Health Care, Medical Device, Biotechnology | $2.3M–$25M |
|
Andy Huynh
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Pat Cummins
Angel
|
1 | Australia, India, France | Seed, Series A | SaaS, Software, Consulting | $999k–$46M |
|
Will Vicars
Angel
|
1 | Australia | Series A, Series B | Health Care, Neuroscience, Bioinformatics | |
|
Sarah McDonald
Angel
|
1 | Australia | Seed | Health Care, Medical Device | |
|
Wilson Wan
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Nicolas de Fontenay
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Amaury Cadet de Fontenay
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Benjamin Zwick
Angel
|
1 | Australia | Pre-Seed | Software, Health Care, Medical Device | |
|
Josh Hannah
Angel
|
1 | United States, Singapore, Norway | Series A, Seed, Series B | Software, Internet, Blockchain | $1.9M–$50M |
| Access all 10 angel investors in Oceania Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Australia, United States, The Netherlands
Investor stats
- Total investments: 9
- Round size: Series A $2.3M–$8.8M; Venture - Series Unknown $3.5M–$25M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — From inspection to insight. We build the Physical AI layer for industrial asset integrity. Get repeatable, decision-ready data and asset life analytics - without confined space entry
Andy Huynh
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Pat Cummins is the Australian Cricket Captain.
Show more...Investment focus
- Industry: SaaS, Software, Consulting
- Stage:Seed, Series A
- Geography: Australia, India, France
Investor stats
- Total investments: 9
- Round size: Seed $999k–$7.5M; Series A $4.5M–$46M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
- Gridsight — Gridsight helps electrical utilities transition to a decentralised grid by creating 90%-accurate, AI-powered load flow models. These models enable utilities to safely and efficiently support more residential solar, batteries and electric vehicles. Based on CEO Brendan Banfield's PhD research, Gridsight was founded in 2020 to accelerate the transition to renewables.
- XO Market — XO Market is a decentralized finance platform that enables users to create, trade, and share prediction-based markets on future events using blockchain technology. The platform operates as a non-custodial interface, allowing participants to interact directly with smart contracts while retaining control of their own crypto assets. XO Marketfacilitates “conviction markets,” where users can establish and trade outcomes on various topics, with prices reflecting collective market sentiment. It uses an automated market maker model to provide liquidity and incorporates a hybrid system combining artificial intelligence and human input to resolve market outcomes. The platform supports permissionless market creation, enabling users to define events, set parameters, and participate in trading without centralized oversight.
Will Vicars is a Chief Investment Officer at Caledonia.
Show more...Investment focus
- Industry: Health Care, Neuroscience, Bioinformatics
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Omniscient Neurotechnology — Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights areilluminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally. For more information, please visit www.o8t.com.
Sarah McDonald
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
Wilson Wan
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Nicolas de Fontenay
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Amaury Cadet de Fontenay
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Benjamin Zwick
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Talk2View — Talk2View is a managed AI infrastructure company simplifying software adoption by enabling conversational commands, currently focused on medical imaging software.
Josh Hannah
Show more...Investment focus
- Industry: Software, Internet, Blockchain
- Stage:Series A, Seed, Series B
- Geography: United States, Singapore, Norway
Investor stats
- Total investments: 61
- Round size: Seed $1.9M–$5.2M; Series A $3.2M–$30M; Series B $7.3M–$50M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Formus — Formus is enabling personalized orthopedics at scale through a fusion of AI-automation with computational biomechanics. Built on 20 years of musculoskeletal research at the Auckland Bioengineering Institute, Formus 3D pre-op planning is FDA, PMDA, and TGA cleared, and has planned over 3,000 hip replacement surgeries at more than 25 sites acrossANZ, Japan, and the US. We are at the next frontier of orthopedics, combining AI-automation with patient-specific modelling of bony and soft-tissue to optimize joint replacement surgeries for each and every patient. Working in tandem with implant manufacturers, we integrate seamlessly into existing industry workflows to reduce costs and vastly increase reliability and scalability. Formus's unique capabilities empower surgeons to revolutionize personalized orthopedics at scale to improve the outcomes of every patient.
- Monkey Tilt — Join your new crypto casino at Monkey Tilt. Play with crypto, earn points & win prizes. Tilt Club VIP program includes bonuses, merch drops & more.
- Ondo Finance — Institutional Grade Finance. On-Chain. For Everyone.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Angel Investors in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 angel investors investing in Oceania Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!